IPWatchdog and LexisNexis and will be offering a webinar entitled "Saving the World with Patents: Is the TRIPS Waiver Helping or Hurting Innovation?" on June 15, 2021 at 11:00 am (ET). Brian Arthur Pomper of Akin Gump; Melissa Brand, Assistant General Counsel, IP, Biotechnology Innovation Organization (BIO); Sarbani Chattopadhyay of LexisNexis; and Gene Quinn of IPWatchdog will discuss the petition by South Africa and India at the World Trade Organization (WTO) to waive most of the protections in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, and whether this is helping or hurting innovation. The panel will also address the following topics:
• The R&D regarding vaccination has been an ongoing process -- you can see the correlation in patent filing statistics with the different virus outbreaks of previous years.
• How patent analytics can provide insight into where a company is focusing their innovations even before they announce the innovations.
• The patent data shows that prior to the Covid-19 outbreak, patents related to SARS and MERS vaccines, mRNA vaccines, and spike protein-based vaccines were already being developed.
• The TRIPS Waiver pros and cons, is it more helpful or harmful to innovation?
There is no registration fee for this webinar. However, those interested in registering for the webinar, should do so here.
Comments